皇冠现金网官网寻求亚洲战略合作伙伴,皇冠代理招募中,皇冠平台开放会员注册、充值、提现、电脑版下载、APP下载。

首页社会正文

哈希定位胆:Malaysian Genomics to undertake private placement exercise

admin2022-08-257

哈希定位胆www.hx198.vip)采用波场区块链高度哈希值作为统计数据,游戏数据开源、公平、无任何作弊可能性,开放单双哈希、幸运哈希、哈希定位胆、哈希牛牛等游戏。

Azri Azerai

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd has proposed to undertake a private placement of up to 10% of its total number of issued shares, to third-party investors to be identified later, at an issue price to be determined later.

The genomics and biopharmaceutical specialist said the new placement shares will rank equally in all respects with existing Malaysian Genomics shares except they will not be entitled to any dividends, rights, allotments and any other forms of distribution should the entitlement date precede the relevant date of allotment and issuance of the new placement shares.

“We are proposing the private placement to raise funds mainly for the group’s future investments of which we are still exploring options and a part of the proceeds will be allocated for the purchase of equipment including IT hardware, biological safety cabinet and extraction automation for our existing and future businesses,” executive director Azri Azerai said in a statement.

,

皇冠注册平台www.hg108.vip)是一个开放皇冠即时比分、皇冠官网注册的平台。皇冠注册平台(www.hg108.vip)专业解决皇冠会员怎么申请开户、怎么申请皇冠信用盘代理、皇冠公司的代理怎么拿的问题。

,

He said the reopening of the economy presents opportunities in the private healthcare segment and the fresh funds raised will enable the company to be able to take advantage of the possibilities.

“We diversified into the biopharmaceutical business in 2020 and have since been pushing to open channels for our cell therapies and genetic tests through a series of agreements that gives us a wider market reach. We also bought a 51% stake in a kidney dialysis operator, Aquahealth Sdn Bhd, to offer holistic kidney care,” he added.

UOB Kay Hian Securities (M) Sdn Bhd is the adviser and placement agent for the proposed private placement.


转载说明:本文转载自Sunbet。

网友评论

热门标签